Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1373 of 5804
-
New drug aims to spare cancer patients from debilitating mouth sores
Symptom relief OngoingThe purpose of this study is to determine if RRx-001, which is added on to the cisplatin and radiation treatment, reduces the incidence of severe oral mucositis in patients with head and neck cancers. All patients in this study will receive 7 weeks of standard of care radiation t…
Phase: PHASE2 • Sponsor: EpicentRx, Inc. • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
New blood test aims to spot lyme disease in kids faster and more accurately
Diagnosis Recruiting nowThe investigators propose a single center, prospective observational study in children with Lyme disease (LD), the Borrelia B-cell diagnostics (BRILLIANT) study, to assess the immune response against Borrelia burgdorferi (Bb) with the following main objectives: 1. Development of…
Sponsor: University Children's Hospital, Zurich • Aim: Diagnosis
Last updated Jun 27, 2026 12:24 UTC
-
Can a new drug shield lung cancer patients from Chemo's worst side effects?
Disease control ENROLLING_BY_INVITATIONThis study is a single arm, exploratory clinical study aimed at evaluating the efficacy and safety of tralazili before chemotherapy in patients with NSCLC.After pathological diagnosis of non-small cell lung cancer(NSCLC), 40 eligible subjects who met the inclusion criteria were s…
Phase: PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
AI spots stealth heart attacks that standard tests miss
Knowledge-focused Recruiting nowThe present study is practice-driven and merely observational and prospective. In clinical routine, patients who suffer from suspected ACS and do not show ST elevation in the ECG, different timing proposals in the guidelines and logistically driven differences lead to considerabl…
Sponsor: Azienda Ospedaliera di Bolzano • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
New cancer drug CRB-701 targets Nectin-4 in advanced tumors
Disease control Recruiting nowThe goal of this clinical trial is to define a safe and effective dose of CRB-701 for participants with solid tumors that are expressing a protein called nectin-4. The main questions it aims to answer are: What is the the safe and effective dose of CRB-701? What cancers can be …
Phase: PHASE1, PHASE2 • Sponsor: Corbus Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New heart valve fix tested without cutting chest open
Disease control Recruiting nowThe study is aimed to assess the safety and feasibility of the Tioga TMVR System in treating patients with symptomatic MR (MR\>=3+)
Phase: NA • Sponsor: Tioga Cardiovascular, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New 'Sandwich' strategy aims to cut leukemia relapse without donor transplant risks
Disease control Recruiting nowAllogeneic hematopoietic stem cell transplantation (allo-HSCT) is the main method potentially curing adult B-ALL, but the high treatment-related mortality (NRM) affects overall survival (OS). Autologous stem cell transplantation (auto-HSCT) can significantly reduce NRM but has a …
Phase: PHASE1 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Brain zaps for tummy troubles: new hope for IBS pain?
Symptom relief CompletedObjective: To identify a central hub of visceral pain in IBS-D and elucidate the mechanism by which repetitive transcranial magnetic stimulation (rTMS) confers analgesic effects. Design: Combined functional magnetic resonance imaging (fMRI) with visceral sensitivity assessments …
Phase: NA • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
New weekly shot shows promise for obesity – but It's early days
Disease control CompletedThe goal of this Phase 1/2 clinical trial is to assess the safety, tolerability, pharmacokinetics, and efficacy of once-weekly subcutaneous injections of MET097 in otherwise healthy adults with overweight or obesity. The trial will be conducted in three parts. Part A consists of…
Phase: PHASE1, PHASE2 • Sponsor: Metsera, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Meditation game aims to sharpen aging brains
Symptom relief Recruiting nowThe goals of the proposed research are to first determine the minimal and/or optimal dose of a digital intervention required for cognitive enhancement, and then to examine the impact of several potential moderators of treatment effects (i.e., cognitive decline, AD polygenic hazar…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Can breast milk or mouthwash stop pneumonia in preterm infants?
Prevention Completedcomparing the effect of oral care with colostrum, chlorohexidine and sodium bicarbonate in prevention of ventilator-associated pneumonia in preterm neonates.
Phase: NA • Sponsor: Tanta University • Aim: Prevention
Last updated Jun 27, 2026 13:03 UTC
-
New Drug-Radiation combo aims to spare bladders in cancer patients
Disease control Recruiting nowThe purpose of this study is to examine the safety and tolerability of treatment with concurrent Sacituzumab Govitecan (SG) and adaptive radiation therapy. The main objective is to establish the safety, tolerability, and feasibility of bladder preservation therapy treatment with …
Phase: PHASE1 • Sponsor: Shilpa Gupta, MD • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could an allergy drug boost brain function in williams syndrome?
Disease control OngoingThis study explores the neurobiological etiology of Williams syndrome and potential therapeutic targets for associated social, motor, and cognitive abnormalities. The main translational objective will be to test the effectiveness of Clemasntine on neurocognitive and other associa…
Phase: PHASE2 • Sponsor: Sheba Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New hearing aid method could help veterans who 'Hear but Can't Understand'
Symptom relief Recruiting nowSince 2000, at least 250,000 U.S. Service members have experienced a blast-related mild traumatic brain injury. A retrospective analysis of over 100,000 post-9/11 Veterans shows that blast injury more than doubles the risk of a diagnosed auditory problem. Many blast-exposed Veter…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Virtual asthma care after ER visits could keep kids breathing easy
Disease control Recruiting nowThe investigators propose a randomized controlled trial of Telehealth-Enhanced Asthma Care for Home After the Emergency Room (TEACH-ER) vs. enhanced care (EC). TEACH-ER includes: 1) brief, pictorial, and health literacy-informed asthma education in the ED, with color- and shape-c…
Phase: NA • Sponsor: University of Rochester • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a single injection stop post-surgery delirium in children?
Symptom relief CompletedThe aim of this study is to confirm the effectiveness of remimazolam in preventing delirium during emergence from anesthesia in children who will undergo elective procedures of tonsillectomy, adenotonsillectomy or adenoidectomy, aged 3-12 years, American Society of Anesthesiologi…
Phase: PHASE1 • Sponsor: University Hospital of Split • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
New combo therapy aims to break the cycle of PTSD and heavy drinking
Symptom relief Recruiting nowThe goal of this clinical trial is to test the efficacy of a novel integrative cognitive-behavioral intervention in patients with posttraumatic stress disorder (PTSD) and alcohol use disorder (AUD). Specific Aim 1: Examine the efficacy of CPT-RP, as compared to RP alone, in redu…
Phase: PHASE2 • Sponsor: Texas A&M University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Ear zap may turbocharge athlete recovery
Symptom relief CompletedThere are few studies in the literature that have evaluated the effects of using percutaneous stimulation of the auricular branch of the vagus nerve for sports purposes (to accelerate recovery after physical exertion). It has been demonstrated that tVNS in athletes improved the r…
Phase: NA • Sponsor: Bakulev Scientific Center of Cardiovascular Surgery • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
Could a urea cycle drug help MCAD patients fast longer?
Disease control TerminatedThis is a medical research study to test a medication in patients 10 years of age and older with a disease called medium-chain acyl-CoA dehydrogenase deficiency (MCADD) caused by the common ACADM c.985 A\>G (K304E) mutation. The medication is sodium phenylbutyrate (ACER-001), whi…
Phase: PHASE2 • Sponsor: Jerry Vockley, MD, PhD • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New eye drops promise sharper night vision for Post-LASIK patients
Symptom relief CompletedSafety and efficacy of 0.75% Phentolamine Ophthalmic Solution to improve mesopic low contrast visual acuity in subjects with post-refractive surgery visual disturbances.
Phase: PHASE3 • Sponsor: Ocuphire Pharma, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC